
Acquired by Agilent Technologies
Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.
Acquired by Agilent Technologies.


SpectaCell develops a fast, label-free single-cell analysis platform that helps biopharma measure how well immune therapies work, from early R&D through manufacturing


